Cargando…
Real clinical impact of drug–drug interactions of immunosuppressants in transplant patients
The main objective was to determine the prevalence of real drug–drug interactions (DDIs) of immunosuppressants in transplant patients. We conducted a prospective, observational 1‐year study at a tertiary hospital, including all transplanted patients. We evaluated data from monitoring blood concentra...
Autores principales: | Gago‐Sánchez, Ana Isabel, Font, Pilar, Cárdenas, Manuel, Aumente, María Dolores, Del Prado, José Ramón, Calleja, Miguel Ángel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578873/ https://www.ncbi.nlm.nih.gov/pubmed/34755493 http://dx.doi.org/10.1002/prp2.892 |
Ejemplares similares
-
New immunosuppressive drugs in heart transplantation
por: Costanzo, Maria Rosa
Publicado: (2001) -
The Effect of Immunosuppressive Drugs on MDSCs in Transplantation
por: Yang, Fan, et al.
Publicado: (2018) -
Drug Interactions between Antimicrobial and Immunosuppressive Agents in Solid Organ Transplant Recipients
por: Bhagat, Vikas, et al.
Publicado: (2021) -
Immunosuppressive Drugs
por: Hussain, Yaseen, et al.
Publicado: (2022) -
Is it ethical to prescribe generic immunosuppressive drugs to renal transplant patients?
por: Allard, Julie, et al.
Publicado: (2014)